Olanzapine Induced Hair Loss: A Case Report

October 2012 in “ Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology ”

Murat Kuloğlu, Sevda Korkmaz, Nilufer Kilic, Sema Sağlam, Mehmet Gürkan Gürok, Murad Atmaca

olanzapine drug-induced alopecia valproic acid lithium atypical antipsychotics

Studysummary This case report describes hair loss associated with olanzapine use, which resolved after discontinuation of the drug, highlighting potential reversible alopecia with atypical antipsychotics.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on tandfonline.com →

Discuss this study in the Community →

Research cited in this study

9 / 9 results

research The Influence of Valproic Acid and Carbamazepine Treatment on Serum Biotin and Zinc Levels and on Biotinidase Activity

21 citations , June 2011 in “Journal of child neurology”

This study found that while serum zinc levels were lower in children treated with valproic acid or carbamazepine than in healthy controls, zinc, biotin, and biotinidase enzyme activity remained within normal ranges and unaffected by these treatments.

research Alopecia Associated with Quetiapine

19 citations , February 2007 in “International Clinical Psychopharmacology”

This study provided the first published case reports of alopecia associated with the use of quetiapine.

research Cutaneous Effects of the Most Commonly Used Antidepressant Medication, the Selective Serotonin Reuptake Inhibitors

55 citations , December 2006 in “Journal of The American Academy of Dermatology”

This review discusses the potential for SSRIs to cause serious skin reactions and suggests considering alternative antidepressants if such reactions occur.

research Olanzapine-Induced Hair Loss: A Case Report

8 citations , November 2002 in “The Canadian journal of psychiatry/Canadian journal of psychiatry”

Increasing olanzapine caused hair loss in a woman, which stopped after changing medication.

research Hair Loss in Psychopharmacology

63 citations , March 2000 in “Annals of clinical psychiatry”

This article reviews the association between psychopharmaceuticals and medication-induced alopecia, noting that hair regrowth typically occurs after discontinuing or reducing the medication, while mineral supplements' effectiveness remains unclear.

research Alopecia Due to Psychotropic Medications

37 citations , May 1999 in “Annals of pharmacotherapy/The annals of pharmacotherapy”

This review describes psychotropic drug-related hair loss as a possible but uncommon side effect, with resolution typically achieved by discontinuing the medication, and emphasizes clinician-patient discussions for managing the condition.

research Alopecia and Mood Stabilizer Therapy

38 citations , September 1996 in “Annals of Clinical Psychiatry”

This review discusses the association between mood stabilizers and alopecia, providing diagnosis insights and management options, but reports no new clinical results.

research Drug-Induced Hair Loss and Hair Growth

147 citations , April 1994 in “Drug Safety”

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

research Psychotropic Medication and Drug-Related Alopecia

30 citations , May 1991 in “Psychosomatics”

This review examines alopecia as a side effect of psychotropic medications, noting that it is typically reversible after stopping the drug, but it reports no new results.